Caption Management, LLC Vaxart, Inc. Transaction History

Caption Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.7 - $5.28 $76,185 - $148,985	-28,217 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$4.29 - $6.64 $121,050 - $187,360	28,217 New	28,217 $142,000
Q2 2021 Aug 16, 2021	SELL	$5.06 - $10.78 $51,738 - $110,225	-10,225 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$5.64 - $23.33 $57,669 - $238,549	10,225 New	10,225 $62,000

8.08M

66.1K

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $46.8M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.